{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:09:37Z","timestamp":1788952177751,"version":"build-2803163510"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/deed.en_GB"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Primary hyperparathyroidism is usually characterized by a monoclonal parathyroid tumor secreting excess parathyroid hormone (PTH). The main regulator of PTH secretion is calcium and the calcium\u2013PTH set point is shifted in parathyroid tumor cells. We sought to investigate the relationship between tumor PTH and<jats:italic>PTH<\/jats:italic>mRNA expression and clinical presentation as well as the regulatory factors including phosphate, vitamin D, and fibroblast growth factor 23.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A total of 154 parathyroid tumors were analyzed by PTH immunohistochemistry and chromogenic<jats:italic>in situ<\/jats:italic>hybridization of<jats:italic>PTH<\/jats:italic>mRNA. A subset of samples (<jats:italic>n<\/jats:italic>= 34) was analyzed using quantitative real-time PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Low tumor<jats:italic>PTH<\/jats:italic>mRNA level was significantly associated with low tumor PTH immunoreactivity (<jats:italic>P<\/jats:italic>= 0.026), but the two did not correlate with regard to histological distribution within individual tumors. Tumors displaying reduced<jats:italic>PTH<\/jats:italic>mRNA levels as compared with normal rim were significantly larger (<jats:italic>P<\/jats:italic>= 0.013) and showed higher expression of the<jats:italic>calcium-s<\/jats:italic>ensing<jats:italic>receptor<\/jats:italic>(<jats:italic>CASR<\/jats:italic>) (<jats:italic>P<\/jats:italic>= 0.046). Weaker tumor<jats:italic>PTH<\/jats:italic>mRNA level was significantly associated with higher concentration of circulating 25-hydroxyvitamin D (<jats:italic>P<\/jats:italic>= 0.005). No significant correlation was seen between PTH immunoreactivity and patient biochemistry. Tumor weight was strongly associated with circulatory concentrations of calcium and PTH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>No areas with apparently higher PTH expression were identified, perhaps suggesting that hyper functioning parathyroid tumor subclones should be rare. Circulating 25-hydroxyvitamin D levels may influence tumor<jats:italic>PTH<\/jats:italic>expression<jats:italic>in vivo<\/jats:italic>. If PTH immunoreactivity reflects the tumor calcium\u2013PTH set point, our data imply that the main determinant of disease severity should be tumor weight.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-15-1062","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T17:30:34Z","timestamp":1455211834000},"page":"583-590","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":10,"title":["Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones"],"prefix":"10.1093","volume":"174","author":[{"given":"Felix","family":"Haglund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimrod B","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga-Lena","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00f6\u00f6g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2016042720035645000_174.5.583.1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","article-title":"Primary hyperparathyroidism: a current perspective","volume":"132","author":"DeLellis","year":"2008","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"2016042720035645000_174.5.583.2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The parathyroid epidemiology and audit research study (PEARS)","volume":"73","author":"Yu","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"2016042720035645000_174.5.583.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0600"},{"key":"2016042720035645000_174.5.583.4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"The Lancet"},{"key":"2016042720035645000_174.5.583.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198803173181102"},{"key":"2016042720035645000_174.5.583.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5311.404"},{"key":"2016042720035645000_174.5.583.7","first-page":"77","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European consortium on MEN1","volume":"611","author":"Lemmens","year":"1997","journal-title":"Human Molecular Genetics"},{"key":"2016042720035645000_174.5.583.8","doi-asserted-by":"publisher","DOI":"10.1038\/ng1048"},{"key":"2016042720035645000_174.5.583.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1743"},{"key":"2016042720035645000_174.5.583.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2303"},{"key":"2016042720035645000_174.5.583.11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.18632\/oncoscience.38","article-title":"Recurrent ZFX mutations in human sporadic parathyroid adenomas","volume":"1","author":"Soong","year":"2014","journal-title":"Oncoscience"},{"key":"2016042720035645000_174.5.583.12","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1046\/j.1523-1755.1999.07303.x","article-title":"Calcium-sensing receptor and calcimimetic agents","volume":"73","author":"Coburn","year":"1999","journal-title":"Kidney International Supplements"},{"key":"2016042720035645000_174.5.583.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.12.4789"},{"key":"2016042720035645000_174.5.583.14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32409"},{"key":"2016042720035645000_174.5.583.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2006.02.016"},{"key":"2016042720035645000_174.5.583.16","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02197"},{"key":"2016042720035645000_174.5.583.17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-3-584"},{"key":"2016042720035645000_174.5.583.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2484"},{"key":"2016042720035645000_174.5.583.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02371.x"},{"key":"2016042720035645000_174.5.583.20","doi-asserted-by":"crossref","unstructured":"Rao DS Honasoge M Divine GW Phillips ER Lee MW Ansari MR Talpos GB Parfitt AM. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. Journal of Clinical Endocrinology and Metabolism 2000 85 1054\u20131058.","DOI":"10.1210\/jc.85.3.1054"},{"key":"2016042720035645000_174.5.583.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0239-y"},{"key":"2016042720035645000_174.5.583.22","doi-asserted-by":"publisher","DOI":"10.1530\/EC-14-0109"},{"key":"2016042720035645000_174.5.583.23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-13-0547","article-title":"Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blinded study","volume":"6","author":"Norenstedt","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"2016042720035645000_174.5.583.24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jbmr.2102","article-title":"Vitamin D supplementation after parathyroidectomy: effects on bone mineral density \u2013 a randomized double-blind study","volume":"4","author":"Norenstedt","year":"2014","journal-title":"Journal of Bone and Mineral Research"},{"key":"2016042720035645000_174.5.583.25","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0021"},{"key":"2016042720035645000_174.5.583.26","unstructured":"DeLellis RA Lloyd RV Heitz PU Eng C Tumours of endocrine organs. In World Health Organization Classification of Tumour Pathology and Genetics, Lyon, France: IARC Press, 2004."},{"key":"2016042720035645000_174.5.583.27","doi-asserted-by":"crossref","unstructured":"Grabinski TM Kneynsberg A Manfredsson FP Kanaan NM. A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating bran sections and primary neuronal cultures. PLoS One 2015 10 e0120120. (doi:10.1371\/journal.pone.0120120)","DOI":"10.1371\/journal.pone.0120120"},{"key":"2016042720035645000_174.5.583.28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.1711650205","article-title":"The expression of parathyroid hormone messenger RNA in normal and abnormal parathyroid tissue","volume":"165","author":"Kendall","year":"1991","journal-title":"Journal of Pathology"},{"key":"2016042720035645000_174.5.583.29","first-page":"1094","article-title":"Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures","volume":"112","author":"Weber","year":"1992","journal-title":"Surgery"},{"key":"2016042720035645000_174.5.583.30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/PL00012285","article-title":"Parathyroid function and histology in patients with parathyroid adenoma: correlation of clinical and morphologic findings","volume":"21","author":"Luts","year":"1997","journal-title":"World Journal of Surgery"},{"key":"2016042720035645000_174.5.583.31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s002689900154","article-title":"Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism","volume":"20","author":"Weber","year":"1996","journal-title":"World Journal of Surgery"},{"key":"2016042720035645000_174.5.583.32","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0085"},{"key":"2016042720035645000_174.5.583.33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02739826","article-title":"Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma, and carcinoma","volume":"2","author":"Tomita","year":"1999","journal-title":"Endocrine Pathology"},{"key":"2016042720035645000_174.5.583.34","doi-asserted-by":"crossref","unstructured":"Weber CJ Russell J Chryssochoos JT Hagler M McGarity WC. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism. World Journal of Surgery 1996 20 1010\u20131014.","DOI":"10.1007\/s002689900154"},{"key":"2016042720035645000_174.5.583.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1319742111"},{"key":"2016042720035645000_174.5.583.36","doi-asserted-by":"crossref","first-page":"e1631","DOI":"10.1210\/jc.2013-1699","article-title":"Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas","volume":"98","author":"Varshney","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016042720035645000_174.5.583.37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.7.2255"},{"key":"2016042720035645000_174.5.583.38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.2000"},{"key":"2016042720035645000_174.5.583.39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114840"},{"key":"2016042720035645000_174.5.583.40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000394"},{"key":"2016042720035645000_174.5.583.41","first-page":"N75","article-title":"Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective","volume":"17","author":"Rao","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"key":"2016042720035645000_174.5.583.42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01081.x"},{"key":"2016042720035645000_174.5.583.43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.3.1054"},{"key":"2016042720035645000_174.5.583.44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bone.2010.10.004","article-title":"Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism","volume":"48","author":"Stein","year":"2011","journal-title":"Bone"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/5\/583.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/5\/583.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T09:08:15Z","timestamp":1718356095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/174\/5\/583\/6655020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":44,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-1062","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}